Actively Recruiting

Phase Not Applicable
Age: 19Years +
All Genders
NCT04299945

Effects of Drinking Beetroot Juice on Exercise Performance in Patients With Fibrotic Interstitial Lung Disease

Led by University of British Columbia · Updated on 2025-01-15

15

Participants Needed

2

Research Sites

125 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Exercise training as part of a structured pulmonary rehabilitation program is a key factor in improving quality of life and symptoms in people with interstitial lung disease (ILD). Optimal methods of exercise training are yet to be explored in ILD. Drinking beetroot juice, which is rich in nitrate, has been shown to improve exercise performance in a variety of groups, but its effects in ILD have not been tested. The purpose of this study is to determine if drinking nitrate-rich beetroot juice can improve exercise performance compared to drinking nitrate-free beetroot juice in people with ILD.

CONDITIONS

Official Title

Effects of Drinking Beetroot Juice on Exercise Performance in Patients With Fibrotic Interstitial Lung Disease

Who Can Participate

Age: 19Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed with idiopathic pulmonary fibrosis, fibrotic nonspecific interstitial pneumonia, chronic hypersensitivity pneumonitis, or unclassifiable ILD matching these diagnoses
  • Presence of fibrosis on lung CT scan showing honeycombing, reticulation, or traction bronchiectasis
  • Oxygen saturation of 92% or higher at rest on room air by pulse oximetry
  • Clinically stable with no worsening symptoms for at least 6 weeks prior
  • Able to read and write fluently in English
Not Eligible

You will not qualify if you...

  • Contraindications to exercise testing such as significant cardiovascular, musculoskeletal, or neurological disease
  • Other major lung or systemic diseases that could reduce exercise capacity or oxygen levels
  • Forced vital capacity (FVC) less than 50% predicted or diffusing capacity of the lungs for carbon monoxide (DLCO) less than 25%
  • Use of prednisone over 10 mg daily for more than 2 weeks within 3 months before study start
  • Presence of a cardiac pacemaker or any metal or electronic implants inside the body

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Providence Health Care - St. Paul's Hosptial

Vancouver, British Columbia, Canada, V6Z 1Y6

Actively Recruiting

2

Vancouver Coastal Health

Vancouver, Canada, V5Z 1M9

Actively Recruiting

Loading map...

Research Team

O

Olivia Ferguson, MSc

CONTACT

D

Dhillon Satvir, MSc

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here